Difluprednate

DRUG7 trials

Sponsors

4d Molecular Therapeutics Inc., Sirion Therapeutics, Inc., University of California, San Francisco

Conditions

InflammationMacular EdemaMacular neovascularization secondary to age-related macular degeneration (nAMD)Uveitis

Phase 3

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

CompletedNCT00430092

Sirion Therapeutics, Inc.Inflammation

Updated: 2009-07-02

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)

CompletedNCT00429923

Sirion Therapeutics, Inc.Inflammation

Updated: 2009-07-02

Study of Difluprednate in the Treatment of Uveitis

CompletedNCT00501579

Sirion Therapeutics, Inc.Uveitis

Updated: 2008-08-29

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)

CompletedNCT00616070

Sirion Therapeutics, Inc.Inflammation

Start: 2007-12-31End: 2008-03-31Target: 120Updated: 2011-06-30

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-004)

CompletedNCT00616993

Sirion Therapeutics, Inc.Inflammation

Start: 2008-01-31End: 2008-03-31Target: 120Updated: 2011-07-01

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial of a Single Intravitreal Injection of 4D-150 in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration (4FRONT-2)

RecruitingCTIS2025-521349-25-00

4d Molecular Therapeutics Inc.Macular neovascularization secondary to age-related macular degeneration (nAMD)

Start: 2025-12-09Target: 298Updated: 2025-12-19

Phase 4

Macular Edema Nepafenac vs. Difluprednate Uveitis Trial

TerminatedNCT01939691

University of California, San FranciscoMacular Edema, Uveitis

Start: 2018-09-12End: 2020-03-31Updated: 2021-01-13

Related Papers

Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.

2010-10-0152 citations